How much should Gilead Sciences charge for its now-authorized COVID-19 therapy remdesivir? Up to $4,460 per patient, an influential pricing watchdog figures. While Gilead has yet to present a marketing plan for the first coronavirus treatment to have shown clinical benefits in a well-designed randomized study, the Institute for Clinical and

  SIGVARIS GROUP is participating in World Lymphedema Day to spread awareness and support the continues search for a cure. World Lymphedema Day is an annual advocate-driven worldwide celebration established in 2016 by the US Senate in response to a bill written by the Lymphatic Education & Research Network (LE&RN)

Alteon Health, backed by private-equity firms Frazier Healthcare Partners and New Mountain Capital, will cut salaries, time off and retirement benefits for providers, citing lost revenue. Several hospitals announced similar cuts. By Isaac Arnsdorf   Emergency room doctors and nurses many of whom are dealing with an onslaught of coronavirus patients

  The Medtronic  Foundation is making an additional $10 million in contributions to COVID-19 relief efforts around the world. The Fridley, Minn.-based company spokesman said that the funds will be put toward training and supervising frontline health workers, ensuring their safety (including the provision of personal protective equipmonprofit partners working

  By Laura Ungar Dr. Jessica Kisoip0s’ twin girls cry most mornings when she goes to work. They’re 9, old enough to know she could catch the coronavirus from her patients and get so sick she could die. Kiss shares that fear and worries at least as much about bringing the virus

by Topher Sanders, David Armstrong and Ava Kofman For ProPublica   A nationwide shortage of two drugs touted as possible treatments for the coronavirus is being driven in part by doctors inappropriately prescribing the medicines for family, friends and themselves, according to pharmacists and state regulators. “It’s disgraceful, is what

  Diagnostics manufacturers with government approval to test for the coronavirus strain COVID-19 are promising millions of tests kits to be produced weekly by the end of March and be commercially available. The Advanced Medical Technology Association (AdvaMed) said at least seven diagnostic companies have now received “emergency use authorization”

  Dear Vein Therapy News clients: The health and safety of our clients and employees is our highest priority. In normal times, we would see you at medical conferences and site visits. Because of the danger of contracting or spreading the coronavirus disease COVID-19, many of us will not be

    By Josh Michaud and Kellie Moss The domestic response to coronavirus in the U.S. is rapidly expanding. At this point, every U.S. state and territory has declared an emergency, and President Trump has declared the pandemic to represent a national emergency. Yet there are concerns that response capabilities

    By Larry Storer The International Vein Conference scheduled for April 30-May 2 in Miami Beach, Florida, has been delayed until July, Chairman Jose I. Almeida said March 20. At the time it was either to be July 9-11 or 10-12. He hopes to have the final date nailed